Webinar – Multi Cancer Early Detection Tools (MCED): The Promise and Challenges
The National Coalition for Cancer Survivorship (NCCS) hosted an insightful webinar discussion exploring the groundbreaking field of multi-cancer early detection (MCED) tools. As advancements in technology and biology open new avenues for cancer screening, the potential to detect multiple cancer types at earlier stages is both promising and complex.
In this conversation, Dr. Otis Brawley brings his extensive experience in oncology, epidemiology, and public health to help us understand the current research questions related to multi-cancer screening, how MCED tools may fit into the broader picture of screening, and clinical implications of early detection strategies. Stacey Tinianov, MPH, a cancer survivor and passionate patient advocate who serves as Executive Director of Advocates for Collaborative Education, shares the cancer survivor perspective on how these tests will impact reducing cancer risk.
The webinar begins with a description of what an MCED is, what what it is not (see slide below), followed by a lively conversation between the speakers moderated by NCCS CEO Shelley Fuld Nasso.
Whether you’re a health care professional or researcher, this webinar will equip you with the knowledge to navigate the evolving landscape of cancer detection. Join us in this critical conversation about the future of cancer care.
Watch the full video below or watch on YouTube.
Webinar Video Chapters
00:00 Introduction
02:20 What is an MCED anyway?
04:08 Otis Brawley: Clinical Overview of MCEDs’
11:08 Stacey Tinianov: Overview of Patient Perspective
14:08 Conversation and Q&A
This Survivorship Champions webinar is supported by Exact Sciences.
About The Speakers
Otis W. Brawley, MD is a globally recognized expert in cancer prevention and control. He has worked to reduce over-screening of medical conditions, which has revolutionized patient treatment by increasing quality of life and reducing health disparities. Dr. Brawley joined Johns Hopkins University as a Bloomberg Distinguished Professor in 2019 from the American Cancer Society and Emory University. He also serves as a member of the Board of Directors of NCCS.
Dr. Brawley’s research focuses on developing cancer screening strategies and ensuring their effectiveness. He has championed efforts to decrease smoking and implement other lifestyle risk reduction programs, as well as to provide critical support to cancer patients and concentrate cancer control efforts in areas where they could be most effective. Dr. Brawley currently leads a broad interdisciplinary research effort on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, striving to close racial, economic, and social disparities in the prevention, detection, and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland.
Stacey Tinianov, MPH, BCPA, is a patient advocate and the founder and executive director of Advocates for Collaborative Education, a non-profit organization dedicated to uniting advocates through pan-cancer collaborations, basic and advanced advocacy education, and the sharing of leading practices across patient, research, and policy advocacy.
As an early stage breast cancer survivor, Stacey’s personal experiences with the healthcare system deeply inform her advocacy efforts and she draws on career experience in education, communications and training, technology, operations, and strategic planning to help elevate patient, community, research, and policy advocacy; build bridges between science, industry, policy, and communities; and to co-create methods of delivering accessible, quality, person-centered care.
Stacey has a Master of Public Health from The Milken Institute School of Public Health at George Washington University.
